Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
09/04/2008 | US20080214601 2-alkylbenzoxazole carboxamides as 5ht3 modulators |
09/04/2008 | US20080214600 Quaternized Quinuclidine Esters |
09/04/2008 | US20080214598 Novel Piperidine Carboxylic Acid Amide Derivatives |
09/04/2008 | US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics |
09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
09/04/2008 | US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
09/04/2008 | US20080213886 Albumin fusion proteins |
09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
09/04/2008 | CA2679126A1 Macrocyclic compound |
09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
09/03/2008 | EP1964839A2 Quinazoline derivatives as kinase inhibitors |
09/03/2008 | EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
09/03/2008 | EP1962855A2 Trpa1 inhibitors for treating pain |
09/03/2008 | EP1480647B1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
09/03/2008 | EP1448234B1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
09/03/2008 | CN101254279A Yiyuan long life health care Chinese medicine |
09/03/2008 | CN101254260A Pharmaceutical combination for curing prostate gland hyperplasy, anuresis and preparation thereof |
09/03/2008 | CN101254242A Applications of Chinese medicinal composition for preparing inhibition angiotensin II receptor |
09/03/2008 | CN101254184A Salviol acid B phosphatide complexes and method of preparing the same |
09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
09/03/2008 | CN100415724C Pyrimidine derivatives |
09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
09/03/2008 | CN100415257C Application of peru apple in preparation of medicine |
09/03/2008 | CN100415256C Chinese traditional medicine preparation for treating uremia |
09/03/2008 | CN100415239C Highly concentrated solution of finasteride and use thereof |
09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
09/02/2008 | US7420053 2-imino-1,3-thiazine derivatives |
09/02/2008 | US7420050 TGF-β-specific covalently closed antisense molecule |
09/02/2008 | US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue |
09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
09/02/2008 | US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
09/02/2008 | US7419950 Methods of inhibiting ectopic calcification |
09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
08/28/2008 | WO2008103847A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
08/28/2008 | WO2008102749A1 Heterocyclic compound |
08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
08/28/2008 | WO2007092720A8 Vitamin d analog: nel, methods and uses thereof |
08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
08/28/2008 | US20080207769 Method for treating benign prostatic hyperplasia |
08/28/2008 | US20080207768 Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom |
08/28/2008 | US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents |
08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
08/28/2008 | US20080207664 Uniform concentration in blood ; oral administering |
08/28/2008 | US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
08/28/2008 | US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/28/2008 | US20080207545 Using antisense oligonucleotides, small interfering RNA, and ribozymes to inhibit expression of the human steroid 5 alpha-reductase gene and thereby inhibit formation of dihydrotestosterone: skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia |
08/28/2008 | US20080206338 Controlled release formulations of an alpha-adrenergic receptor antagonist |
08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
08/27/2008 | EP1961756A1 Novel bisboron compound |
08/27/2008 | EP1961751A1 Acid addition salt of optically active dihydropyridine derivative |
08/27/2008 | EP1961749A1 Acid addition salt of dihydropyridine derivative |
08/27/2008 | EP1961420A1 Agent for prevention and treatment of acute renal failure |
08/27/2008 | EP1961418A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer |
08/27/2008 | EP1961309A1 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof |
08/27/2008 | EP1660484B1 Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |
08/27/2008 | EP1337560B1 Truncated cd200 |
08/27/2008 | EP1313714B1 Valsartan salts |
08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
08/27/2008 | EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease |
08/27/2008 | EP1089994B9 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
08/27/2008 | CN101253159A Diaminopyrimidines as P2X3 and P2X2/3 modulators |
08/27/2008 | CN101250136A 1,3-diaryl-3-aryl amidine-1-acetoxime compounds, preparation method and use thereof |
08/27/2008 | CN101250134A N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof |
08/27/2008 | CN101249261A Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same |
08/27/2008 | CN101249258A An uro-genital condition treatment system |
08/27/2008 | CN101249239A Traditional Chinese medicine preparation for curing chyluria |
08/27/2008 | CN101249231A Medicine composition for treating lithiasis and preparation thereof |
08/27/2008 | CN101249229A Chinese medicine preparation for curing bloody stranguria type cystitis |
08/27/2008 | CN101249178A Reinforced immunity and kidney tonifying health care medicinal liquor and preparing same thereof |
08/27/2008 | CN101249171A Calculi discharging medicament |
08/27/2008 | CN101249170A Preparation of houttuynia cordata freeze-dried powder needle for injections |
08/27/2008 | CN101249168A Traditional Chinese medicine preparation for curing heat stranguria |
08/27/2008 | CN101249135A Compound urolithic stranguria unlock capsules and preparation technique thereof |
08/27/2008 | CN101248863A Method for processing medlar bud appetizer food |
08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
08/27/2008 | CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
08/27/2008 | CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same |
08/27/2008 | CN100413852C Valsartan salts |
08/27/2008 | CN100413531C Chinese medicine preparation for treating calculus |
08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
08/26/2008 | US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |